Autoimmunity and asbestos exposure

Autoimmune Diseases

Volumn 2014, Issue , 2014, Pages

  Pfau, Jean C ^a   Serve, Kinta M ^a   Noonan, Curtis W ^b  

^a Nucl Eng Idaho State University   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBOLE; ASBESTOS; AUTOANTIBODY; CHRYSOTILE; INFLAMMASOME; NANOMATERIAL; SERPENTINE; SILICATE; SILICON DIOXIDE; TREMOLITE; VERMICULITE; ZEOLITE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISEASE ASSOCIATION; DUST; EXPOSURE; HUMAN; IMMUNE COMPLEX DEPOSITION; IN VITRO STUDY; INDUSTRIAL WORKER; LATENT PERIOD; LUNG DISEASE; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PLEURA DISEASE; PROTEIN DEGRADATION; PROTEINURIA; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TEXTILE WORKER; UBIQUITINATION;

EID: 84901332980     PISSN: 20900422     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2014/782045     Document Type: Review

References (102)

1. Germolec D., Kono D. H., Pfau J., Pollard K., Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. Journal of Autoimmunity 2012 39 4 285 293 10.1016/j.jaut.2012.05.020
2. Cooper G. S., Gilbert K. M., Greidinger E. L., James J. A., Pfau J. C., Reinlib L., Richardson B. C., Rose N. R., Recent advances and opportunities in research on Lupus: environmental influences and mechanisms of disease. Environmental Health Perspectives 2008 116 6 695 702 2-s2.0-44949088275 10.1289/ehp.11092 (Pubitemid 351943922)
3. Brown J. M., Pfau J. C., Pershouse M. A., Holian A., Silica, apoptosis, and autoimmunity. Journal of Immunotoxicology 2005 1 3 177 187 10.1080/15476910490911922
4. Pfau J. C., Brown J. M., Holian A., Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004 195 2-3 167 176 2-s2.0-1642534473 10.1016/j.tox.2003.09.011 (Pubitemid 38125117)
5. Brown J. M., Archer A. J., Pfau J. C., Holian A., Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clinical and Experimental Immunology 2003 131 3 415 421 2-s2.0-0037340279 10.1046/j.1365-2249.2003.02094.x (Pubitemid 36324131)
6. Brown J. M., Pfau J. C., Holian A., Immunoglobulin and lymphocyte responses following silica exposure in New Zealand Mixed Mice. Inhalation Toxicology 2004 16 3 133 139 2-s2.0-1642342693 10.1080/08958370490270936 (Pubitemid 38372556)
7. Sporn T. A., Mineralogy of asbestos. Recent Results in Cancer Research 2011 189 1 11 2-s2.0-79955004097 10.1007/978-3-642-10862-4-1
8. Gwinn M. R., Multiple modes of action of asbestos and related mineral fibers. Journal of Toxicology and Environmental Health B: Critical Reviews 2011 14 1-4 1 2 2-s2.0-79959267459 10.1080/10937404.2011.556044
9. Gwinn M. R., Devoney D., Jarabek A. M., Sonawane B., Wheeler J., Weissman D. N., Masten S., Thompson C., Meeting report: mode(s) of action of asbestos and related mineral fibers. Environmental Health Perspectives 2011 119 12 1806 1810 2-s2.0-82755162784
10. Carbone M., Yang H., Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clinical Cancer Research 2012 18 3 598 604 2-s2.0-84856520749 10.1158/1078-0432.CCR-11-2259
11. Ryan P. H., Dihle M., Griffin S., Partridge C., Hilbert T. J., Taylor R., Adjei S., Lockey J. E., Erionite in road gravel associated with interstitial and pleural changes-an occupational Hazard in Western United States. Journal of Occupational and Environmental Medicine 2011 53 8 892 898 2-s2.0-80051781410 10.1097/JOM.0b013e318223d44c
12. Van Gosen B. S., Blitz T. A., Plumlee G. S., Meeker G. P., Pierson M. P., Geologic occurrences of erionite in the United States: an emerging national public health concern for respiratory disease. Environmental Geochemistry and Health 2013 35 4 419 430 10.1007/s10653-012-9504-9
13. Kim J. S., Song K. S., Lee J. K., Toxicogenomic comparison of multi-wall carbon nanotubes (MWCNTs) and asbestos. Archives of Toxicology 2012 86 4 553 562 10.1007/s00204-011-0770-6
14. Shvedova A. A., Yanamala N., Kisin E. R., Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year post exposure comparisons. American Journal of Physiology-Lung Cellular and Molecular Physiology 2014 306 2 L170 L182 10.1152/ajplung.00167.2013
15. Aust A. E., Cook P. M., Dodson R. F., Morphological and chemical mechanisms of elongated mineral particle toxicities. Journal of Toxicology and Environmental Health B: Critical Reviews 2011 14 1-4 40 75 2-s2.0-79959200382 10.1080/10937404.2011.556046
16. Rom W. N., Travis W. D., Brody A. R., Cellular and molecular basis of the asbestos-related diseases. American Review of Respiratory Disease 1991 143 2 408 422 2-s2.0-0026078961
17. Rosenthal G. J., Simeonova P., Corsini E., Asbestos toxicity: an immunologic perspective. Reviews on Environmental Health 1999 14 1 11 20 2-s2.0-0032842269 (Pubitemid 29396636)
18. Pernis B., Vigliani E. C., Selikoff I. J., Rheumatoid factor in serum of individuals exposed to asbestos. Annals of the New York Academy of Sciences 1965 132 1 112 120 2-s2.0-0013857467
19. Nigam S. K., Suthar A. M., Patel M. M., Karnik A. B., Dave S. K., Kashyap S. K., Venkaiah K., Humoral immunological profile of workers exposed to asbestos in asbestos mines. The Indian Journal of Medical Research 1993 98 274 277 2-s2.0-0027755755
20. Pfau J. C., Sentissi J. J., Weller G., Putnam E. A., Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environmental Health Perspectives 2005 113 1 25 30 2-s2.0-12744279388 10.1289/ehp.7431
21. Stansfield D., Edge J. R., Circulating rheumatoid factor and antinuclear antibodies in shipyard asbestos workers with pleural plaques. British Journal of Diseases of the Chest 1974 68 3 166 170 2-s2.0-0016167687
22. Tamura M., Dong L., Tokuyama T., Yoneda T., Kasuga H., Narita N., Sada K., Miyazaki R., Okada S., Study on the relationship between appearance of autoantibodies and chest X-ray findings of asbestos plant employees. Japanese Journal of Industrial Health 1993 35 5 406 412 2-s2.0-0027384358 (Pubitemid 23323196)
23. Turner-Warwick M., Parkes W. R., Circulating rheumatoid and antinuclear factors in asbestos workers. British Medical Journal 1970 3 721 492 495 2-s2.0-0014967064
24. Zerva L. V., Constantopoulos S. H., Moutsopoulos H. M., Humoral immunity alterations after environmental asbestos exposure. Respiration 1989 55 4 237 241 2-s2.0-0024444004 (Pubitemid 19279148)
25. Huuskonen M. S., Rasanen J. A., Harkonen H., Asp S., Asbestos exposure as a cause of immunological stimulation. Scandinavian Journal of Respiratory Diseases 1978 59 6 326 332 2-s2.0-0018217639 (Pubitemid 9140437)
26. de Shazo R. D., Hendrick D. J., Diem J. E., Immunologic aberrations in asbestos cement workers: dissociation from asbestosis. Journal of Allergy and Clinical Immunology 1983 72 5 454 461 2-s2.0-0021048137 (Pubitemid 14206011)
27. Zone J. J., Rom W. N., Circulating immune complexes in asbestos workers. Environmental Research 1985 37 2 383 389 2-s2.0-0021885649 10.1016/0013-9351(85) 90119-7 (Pubitemid 15020147)
28. Pfau J. C., Blake D. J., Fritzler M. J., Vogel F. L., Zimmermann L. F., Autoantibody profiles of an asbestos-exposed population. Autoimmunity: Role, Regulation and Disorders 2009 New York, NY, USA Nova Science 245 268
29. Lange A., An epidemiological survey of immunological abnormalities in asbestos workers. I. Nonorgan and organ-specific autoantibodies. Environmental Research 1980 22 1 162 175 2-s2.0-0019194587 (Pubitemid 11217987)
30. Kumagai-Takei N., Maeda M., Chen Y., Asbestos induces reduction of tumor immunity. Clinical and Developmental Immunology 2011 2011 9 481439 10.1155/2011/481439
31. Meeker G. P., Bern A. M., Brownfield I. K., Lowers H. A., Sutley S. J., Hoefen T. M., Vance J. S., The composition and morphology of amphiboles from the Rainy Creek complex, near Libby, Montana. American Mineralogist 2003 88 11-12 1955 1969 2-s2.0-0347900582 (Pubitemid 38098172)
32. Buck B. J., Goossens D., Metcalf R. V., McLaurin B., Ren M., Freudenberger F., Naturally occurring asbestos: potential for human exposure, Southern Nevada, USA. Soil Science Society of America Journal 2013 77 2192 2204
33. Turner Warwick M., Immunology and asbestosis. Proceedings of the Royal Society of Medicine 1973 66 9 927 930 2-s2.0-0015857807
34. Toivanen A., Salmivalli M., Molnar G., Pulmonary asbestosis and autoimmunity. British Medical Journal 1976 1 6011 691 692 2-s2.0-0017263188
35. Kagan E., Solomon A., Cochrane J. C., Immunological studies of patients with asbestosis. I. Studies of cell mediated immunity. Clinical and Experimental Immunology 1977 28 1 261 267 2-s2.0-0017741062 (Pubitemid 8119973)
36. Haslam P. L., Lukoszek A., Merchant J. A., Turner-Warwick M., Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clinical and Experimental Immunology 1978 31 2 178 188 2-s2.0-0018092331 (Pubitemid 8322706)
37. Doll N. J., Diem J. E., Jones R. N., Humoral immunologic abnormalities in workers exposed to asbestos cement dust. Journal of Allergy and Clinical Immunology 1983 72 5 509 512 2-s2.0-0021088181 (Pubitemid 14206019)
38. Tamura M., Tokuyama T., Kasuga H., Yoneda T., Miyazaki R., Narita N., Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees. Journal of Occupational Health 1996 38 3 138 141 2-s2.0-0030002569 (Pubitemid 26164525)
39. Ferro A., Zebedeo C. N., Davis C., Ng K. W., Pfau J. C., Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. Journal of Immunotoxicology 2013 10.3109/1547691X.2013.847510
40. Pfau J. C., Sentissi J. J., Li S., Calderon-Garcidueńas L., Brown J. M., Blake D. J., Asbestos-induced autoimmunity in C57Bl/6 mice. Journal of Immunotoxicology 2008 5 2 129 137 2-s2.0-45849122133 10.1080/15476910802085756 (Pubitemid 351882431)
41. Salazar K. D., Copeland C. B., Wood C. E., Schmid J. E., Luebke R. W., Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. Journal of Immunotoxicology 2012 10 4 329 333
42. Salazar K. D., Copeland C. B., Luebke R. W., Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. Journal of Toxicology and Environmental Health A: Current Issues 2012 75 6 351 365 2-s2.0-84859757330 10.1080/15287394.2012.668164
43. Pfau J. C., Li S., Holland S., Sentissi J. J., Alteration of fibroblast phenotype by asbestos-induced autoantibodies. Journal of Immunotoxicology 2011 8 2 159 169 2-s2.0-79955619518 10.3109/1547691X.2011.562257
44. Heinlen L. D., McClain M. T., Merrill J., Akbarali Y. W., Edgerton C. C., Harley J. B., James J. A., Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis and Rheumatism 2007 56 7 2344 2351 2-s2.0-34547426477 10.1002/art.22665 (Pubitemid 47173582)
45. Noonan C. W., Pfau J. C., Nriagu J., Asbestos exposure and autoimmune disease. Encyclopedia of Environmental Health 2011 New York, NY, USA Elsevier 193 203
46. Greaves I. A., Rheumatoid "pneumoconiosis" (Caplan's syndrome) in an asbestos worker: a 17 years' follow-up. Thorax 1979 34 3 404 405 2-s2.0-0018743785 (Pubitemid 9223991)
47. Noonan C. W., Pfau J. C., Larson T. C., Spence M. R., Nested case-control study of autoimmune disease in an asbestos-exposed population. Environmental Health Perspectives 2006 114 8 1243 1247 2-s2.0-33746925280 10.1289/ehp.9203 (Pubitemid 44184684)
48. Olsson R. A., Skogh T., Axelson O., Wingren G., Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occupational and Environmental Medicine 2004 61 3 233 238 2-s2.0-1542509953 10.1136/oem.2003.007971 (Pubitemid 38339899)
49. Gold L. S., Ward M. H., Dosemeci M., De Roos A. J., Systemic autoimmune disease mortality and occupational exposures. Arthritis and Rheumatism 2007 56 10 3189 3201 2-s2.0-35348923834 10.1002/art.22880 (Pubitemid 47585413)
50. Inoue T., Tanaka E., Kato T., Sakuramoto M., Minakuchi M., Maeda Y., Maniwa K., Terada K., Goto S., Takeda T., Yuba Y., Kobashi Y., Noma S., Taguchi Y., A case of MPO-ANCA-related vasculitis after asbestos exposure with progression of a renal lesion after improvement of interstitial pneumonia. Nihon Kokyuki Gakkai Zasshi 2004 42 6 496 501 2-s2.0-4143123497
51. Rihova Z., Maixnerova D., Jancova E., Pelclova D., Bartunkova J., Fenclova Z., Vankova Z., Reiterova J., Merta M., Rysava R., Tesar V., Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvement. Renal Failure 2005 27 5 605 608 2-s2.0-24044451510 10.1080/08860220500200395 (Pubitemid 41216319)
52. Stratta P., Messuerotti A., Canavese C., Coen M., Luccoli L., Bussolati B., Giorda L., Malavenda P., Cacciabue M., Bugiani M., Bo M., Ventura M., Camussi G., Fubini B., The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. Science of the Total Environment 2001 270 1-3 179 190 2-s2.0-0035836955 (Pubitemid 32753120)
53. Maguire G. P., Meggs L. G., Addonizio J., Del Guercio L. R. M., Association of asbestos exposure, retroperitoneal fibrosis, and acute renal failure. New York State Journal of Medicine 1991 91 8 357 359 2-s2.0-0025899294
54. Sauni R., Oksa P., Jarvenpaa R., Parker J. E., Roto P., Asbestos exposure: a potential cause of retroperitoneal fibrosis. American Journal of Industrial Medicine 1998 33 4 418 421 (Pubitemid 28150504)
55. Uibu T., Oksa P., Auvinen A., Honkanen E., Metsärinne K., Saha H., Uitti J., Roto P., Asbestos exposure as a risk factor for retroperitoneal fibrosis. The Lancet 2004 363 9419 1422 1426 2-s2.0-2342455206 10.1016/S0140-6736(04)16100-X (Pubitemid 38586717)
56. Vaglio A., Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine 2009 88 4 208 210 2-s2.0-67651089843 10.1097/MD.0b013e3181afc4d1
57. van Bommel E. F., Jansen I., Hendriksz T. R., Aarnoudse A. L., Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine 2009 88 4 193 201 2-s2.0-67651083578 10.1097/MD.0b013e3181afc420
58. Uibu T., Vanhala E., Sajantila A., Lunetta P., Mäkelä-Bengs P., Goebeler S., Jäntti M., Tossavainen A., Asbestos fibers in para-aortic and mesenteric lymph nodes. American Journal of Industrial Medicine 2009 52 6 464 470 2-s2.0-66349098141 10.1002/ajim.20694
59. Bunderson-Schelvan M., Pfau J. C., Crouch R., Holian A., Nonpulmonary outcomes of asbestos exposure. Journal of Toxicology and Environmental Health B: Critical Reviews 2011 14 1-4 122 152 2-s2.0-79959229079 10.1080/10937404.2011. 556048
60. Goswami E., Craven V., Dahlstrom D. L., Alexander D., Mowat F., Domestic asbestos exposure: a review of epidemiologic and exposure data. International Journal of Environmental Research and Public Health 2013 10 11 5629 5670
61. Noonan C. W., Exposure matrix development for the Libby cohort. Inhalation Toxicology 2006 18 12 963 967 2-s2.0-33747678775 10.1080/ 08958370600835021 (Pubitemid 44272887)
62. Heinlen L. D., Ritterhouse L. L., McClain M. T., Keith M. P., Neas B. R., Harley J. B., James J. A., Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. Journal of Molecular Medicine 2010 88 7 719 727 2-s2.0-77954543289 10.1007/s00109-010-0618-1
63. Birch E., Serve K. M., Pfau J. C., Comparison of serum autoantibody prevalence in asbestos-exposed populations: Libby, MT and New York Pipefitters. Proceedings of the National Conference for Undergraduate Research 2012 Ogden, Utah, USA Weber State University
64. Bernstein D., Dunnigan J., Hesterberg T., Health risk of chrysotile revisited. Critical Reviews in Toxicology 2013 43 2 154 183 10.3109/10408444. 2012.756454
65. Craighead J. E., Mossman B. T., Bradley B. J., Comparative studies on the cytotoxicity of amphibole and serpentine asbestos. Environmental Health Perspectives 1980 34 37 46 2-s2.0-0019230798 (Pubitemid 10016962)
66. Donaldson K., Murphy F. A., Duffin R., Poland C. A., Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Particle and Fibre Toxicology 2010 7 5 2-s2.0-77952317021 10.1186/1743-8977-7-5
67. Marchand L. S., St-Hilaire S., Putnam E. A., Serve K. M., Pfau J. C., Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT. Toxicology Letters 2012 208 2 168 173 2-s2.0-82055185576 10.1016/j.toxlet.2011.10.024
68. Cyphert J. M., Nyska A., Mahoney R. K., Schladweiler M. C., Kodavanti U. P., Gavett S. H., Sumas Mountain chrysotile induces greater lung fibrosis in Fischer344 rats than Libby amphibole, El Dorado tremolite, and Ontario ferroactinolite. Toxicological Sciences 2012 130 2 405 415 10.1093/toxsci/kfs249
69. Nishimura Y., Maeda M., Kumagai-Takei N., Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases. Environmental Health and Preventive Medicine 2013 18 3 198 204 10.1007/s12199-013-0333-y
70. Otsuki T., Maeda M., Murakami S., Immunological effects of silica and asbestos. Cellular & Molecular Immunology 2007 4 4 261 268
71. Kumagai-Takei N., Nishimura Y., Maeda M., Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in MLR of human PBMCs. American Journal of Respiratory Cell and Molecular Biology 2013 49 1 28 36
72. Li M., Gunter M. E., Fukagawa N. K., Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby, "six-mix" amphiboles and subsequent activation of BEAS-2B cells. Cytokine 2012 60 3 718 730 10.1016/j.cyto.2012.08.025
73. Furuzawa-Carballeda J., Vargas-Rojas M. I., Cabral A. R., Autoimmune inflammation from the Th17 perspective. Autoimmunity Reviews 2007 6 3 169 175 2-s2.0-33846608583 10.1016/j.autrev.2006.10.002 (Pubitemid 46187336)
74. Afzali B., Lombardi G., Lechler R. I., Lord G. M., The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 2007 148 1 32 46 2-s2.0-33847667225 10.1111/j.1365-2249.2007.03356.x (Pubitemid 46365005)
75. Kotake S., Kamatani N., The role of IL-17 in joint destruction. Drug News and Perspectives 2002 15 1 17 23 2-s2.0-0036202620 10.1358/dnp.2002.15.1.660504 (Pubitemid 34262942)
76. Rodriguez-Reyna T. S., Furuzawa-Carballeda J., Cabiedes J., Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatology International 2012 32 9 2653 2660 10.1007/s00296-011-2056-y
77. Hillegass J. M., Shukla A., MacPherson M. B., Lathrop S. A., Alexeeva V., Perkins T. N., van der Vliet A., Vacek P. M., Gunter M. E., Mossman B. T., Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells. Particle and Fibre Toxicology 2010 7 26 2-s2.0-77956458390 10.1186/1743-8977-7-26
78. Marczynski B., Czuppon A. B., Marek W., Reichel G., Baur X., Increased incidence of DNA double strand breaks and anti-ds DNA antibodies in blood of workers occupationally exposed to asbestos. Human and Experimental Toxicology 1994 13 1 3 9 2-s2.0-0028158912 (Pubitemid 24029630)
79. Pelclová D., Bartůňková J., Fenclová Z., Lebedová J., Hladíková M., Benáková H., Asbestos exposure and antineutrophil cytoplasmic antibody (ANCA) positivity. Archives of Environmental Health 2003 58 10 662 668 2-s2.0-8344232226 10.3200/AEOH.58.10.662-668 (Pubitemid 39482416)
80. Marie I., Josse S., Hatron P. Y., Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care & Research 2013 65 5 800 808 10.1002/acr.21895
81. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 320 5876 674 677 2-s2.0-43249125839 10.1126/science.1156995 (Pubitemid 351928351)
82. Shannahan J. H., Ghio A. J., Schladweiler M. C., Richards J. H., Andrews D., Gavett S. H., Kodavanti U. P., Transcriptional activation of inflammasome components by Libby amphibole and the role of iron. Inhalation Toxicology 2012 24 1 60 69 2-s2.0-84855491363 10.3109/08958378.2011.633942
83. Holian A., Uthman M. O., Goltsova T., Brown S. D., Hamilton R. F. Jr., Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environmental Health Perspectives 1997 105 supplement 5 1139 1142 2-s2.0-0031218368
84. Overocker J., Pfau J. C., Cytokine production modified by system X(c)- after PM10 and asbestos exposure. Journal of Young Investigators 2012 23 6 34 39
85. Perkins R. C., Scheule R. K., Hamilton R., Gomes G., Freidman G., Holian A., Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Experimental Lung Research 1993 19 1 55 65 2-s2.0-0027397690 (Pubitemid 23042788)
86. Perkins R. C., Scheule R. K., Holian A., In Vitro bioactivity of asbestos for the human alveolar macrophage and its modification by IgG. American Journal of Respiratory Cell and Molecular Biology 1991 4 6 532 537 2-s2.0-0026176157
87. Biswas R., Bunderson-Schelvan M., Holian A., Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulmonary Medicine 2011 2011 8 105707 10.1155/2011/105707
88. Blake D. J., Wetzel S. A., Pfau J. C., Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology 2008 246 2-3 172 179 2-s2.0-40649092277 10.1016/j.tox.2008.01.008
89. Casciola-Rosen L. A., Anhalt G., Rosen A., Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. Journal of Experimental Medicine 1994 179 4 1317 1330 2-s2.0-0028288510 (Pubitemid 24091790)
90. Wada K., Kamitani T., Autoantigen Ro52 is an E3 ubiquitin ligase. Biochemical and Biophysical Research Communications 2006 339 1 415 421 2-s2.0-28144464728 10.1016/j.bbrc.2005.11.029 (Pubitemid 41697564)
91. Broaddus V. C., Yang L., Scavo L. M., Ernst J. D., Boylan A. M., Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. Journal of Clinical Investigation 1996 98 9 2050 2059 2-s2.0-0029962683 (Pubitemid 26376293)
92. Hamilton R. F., Li L., Iyer R., Holian A., Asbestos induces apoptosis in human alveolar macrophages. American Journal of Physiology-Lung Cellular and Molecular Physiology 1996 271 5, part 1 L813 L819 2-s2.0-0029954573
93. Gregor A., Parkes R. W., Du Bois R., Turner-Warwick M., Radiographic progression of asbestosis: preliminary report. Annals of the New York Academy of Sciences 1979 330 147 156 2-s2.0-0018650773 (Pubitemid 11223557)
94. Peipins L. A., Lewin M., Campolucci S., Lybarger J., Miller A., Middleton D., Weis C., Spence M., Black B., Kapil V., Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environmental Health Perspectives 2003 111 14 1753 1759 2-s2.0-10744220069 (Pubitemid 37407936)
95. del Papa N., Meroni P. L., Barcellini W., Sinico A., Radice A., Tincani A., D'Cruz D., Nicoletti F., Borghi M. O., Khamashta M. A., Hughes G. R. V., Balestrieri G., Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clinical Immunology and Immunopathology 1992 63 3 267 274 2-s2.0-0026632718 10.1016/0090-1229(92)90232-D
96. Ihn H., Sato S., Fujimoto M., Igarashi A., Yazawa N., Kubo M., Kikuchi K., Takehara K., Tamaki K., Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clinical and Experimental Immunology 2000 119 1 203 209 2-s2.0-0033983441 10.1046/j.1365-2249.2000.01115.x (Pubitemid 30064611)
97. Renaudineau Y., Dugué C., Dueymes M., Youinou P., Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmunity Reviews 2002 1 6 365 372 2-s2.0-0042970242 10.1016/S1568-9972(02)00063-0 (Pubitemid 38340250)
98. Chizzolini C., Raschi E., Rezzonico R., Testoni C., Mallone R., Gabrielli A., Facchini A., Del Papa N., Borghi M. O., Dayer J. M., Meroni P. L., Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis and Rheumatism 2002 46 6 1602 1613 2-s2.0-0036269002 10.1002/art.10361 (Pubitemid 34620208)
99. Fineschi S., Goffin L., Rezzonico R., Cozzi F., Dayer J., Meroni P. L., Chizzolini C., Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. Arthritis and Rheumatism 2008 58 12 3913 3923 2-s2.0-57349109321 10.1002/art.24049
100. Ronda N., Raschi E., Testoni C., Anti-fibroblast antibodies in systemic sclerosis. Israel Journal of Medical Sciences 2002 4 supplement 11 858 864 (Pubitemid 35291252)
101. Serve K. M., Black B., Szeinuk J., Pfau J. C., Asbestos-associated mesothelial cell autoantibodies promote collagen deposition in vitro. Inhalation Toxicology 2013 25 14 774 784
102. Baroni S. S., Santillo M., Bevilacqua F., Luchetti M., Spadoni T., Mancini M., Fraticelli P., Sambo P., Funaro A., Kazlauskas A., Avvedimento E. V., Gabrielli A., Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. New England Journal of Medicine 2006 354 25 2667 2676 2-s2.0-33745277147 10.1056/NEJMoa052955